We are live on
!
Find out more
FOLD
Amicus Therapeutics
FOLD
FOLD
Delisted
FOLD was delisted on the 24th of April, 2026.
297 hedge funds and large institutions have $4.79B invested in Amicus Therapeutics in 2026 Q1 according to their latest regulatory filings, with 52 funds opening new positions, 110 increasing their positions, 89 reducing their positions, and 80 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more ownership
Funds ownership: →
5% more capital invested
Capital invested by funds: $4.57B → $4.79B (+$224M)
11% less funds holding
Funds holding: 332 → 297 (-35)
35% less first-time investments, than exits
New positions opened: 52 | Existing positions closed: 80
Holders
297
Holding in Top 10
16
Calls
$9.21M
Puts
$6.76M
Top Buyers
| 1 | +$166M | |
| 2 | +$159M | |
| 3 | +$144M | |
| 4 |
Goldman Sachs
New York
|
+$77.6M |
| 5 |
Millennium Management
New York
|
+$70.4M |
Top Sellers
| 1 | -$153M | |
| 2 | -$151M | |
| 3 | -$92.7M | |
| 4 |
PA
Perceptive Advisors
New York
|
-$90.7M |
| 5 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
-$74.2M |
